Orthofix Medical (OFIX) to Release Earnings on Tuesday

Orthofix Medical (NASDAQ:OFIX - Get Free Report) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 7th. Analysts expect Orthofix Medical to post earnings of ($0.32) per share for the quarter. Persons that wish to listen to the company's earnings conference call can do so using this link.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last issued its earnings results on Tuesday, March 5th. The medical device company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.60) by $0.01. The business had revenue of $200.42 million during the quarter. Orthofix Medical had a negative net margin of 20.28% and a negative return on equity of 10.63%. On average, analysts expect Orthofix Medical to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Orthofix Medical Stock Performance

NASDAQ OFIX traded down $0.09 during trading on Tuesday, reaching $13.00. 365,822 shares of the company's stock were exchanged, compared to its average volume of 402,547. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.54 and a quick ratio of 1.20. The business has a 50 day moving average price of $13.66 and a 200-day moving average price of $12.97. The stock has a market capitalization of $486.33 million, a P/E ratio of -3.17 and a beta of 1.04. Orthofix Medical has a fifty-two week low of $9.57 and a fifty-two week high of $21.60.

Analyst Upgrades and Downgrades

OFIX has been the topic of several research reports. StockNews.com downgraded shares of Orthofix Medical from a "hold" rating to a "sell" rating in a report on Wednesday, March 6th. Roth Mkm increased their price target on shares of Orthofix Medical from $12.00 to $15.00 and gave the company a "neutral" rating in a report on Thursday, March 7th. Finally, JMP Securities restated a "market perform" rating on shares of Orthofix Medical in a research report on Monday, April 22nd. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. According to data from MarketBeat.com, Orthofix Medical has a consensus rating of "Hold" and an average target price of $15.50.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.